Kamil Adamczyk

Dr. Kamil Adamczyk

Anaesthesiology and Intensive Therapy, National Medical Institute of the Ministry of Interior Affairs and Administration, Warsaw, Mazowieckie, Poland
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2018 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
ACAgnieszka Cholewiak
Agnieszka Cholewiak
Kamil AdamczykKamil Adamczyk
Kamil Adamczyk
MKMichał Kopyt
Michał Kopyt
AKAdrian Kasztelan
Adrian Kasztelan
PKPiotr Kwiatkowski
Piotr Kwiatkowski
A highly enantioselective and relatively fast (1–5 h) Michael reaction with substantial reduction of organocatalyst loading (0.2–1 mol%) was developed under high-pressure conditions (up to 9 kbar) and at room temperature.

Kamil AdamczykKamil Adamczyk
Kamil Adamczyk
Kamil KoszelaKamil Koszela
Kamil Koszela
AZArtur Zaczyński
Artur Zaczyński
MNMarcin Niedźwiecki
Marcin Niedźwiecki
SBSybilla Brzozowska-Mankowska
Sybilla Brzozowska-Mankowska
RGRobert Gasik
Robert Gasik
Postoperative pain is common following spine surgery, particularly complex procedures. The main anesthetic efforts are focused on applying multimodal analgesia beforehand, and regional anesthesia is a critical component of it. The purpose of this study is to examine the existing techniques for regional anesthesia in cervical spine surgery and to determine their effect and safety on pain reduction and postoperative patient’s recovery. The electronic databases were searched for all literature pertaining to cervical nerve block procedures. The following peripheral, cervical nerve blocks were selected and described: paravertebral block, cervical plexus clock, paraspinal interfascial plane blocks such as multifidus cervicis, retrolaminar, inter-semispinal and interfacial, as well as erector spinae plane block and stellate ganglion block. Clinicians should choose more superficial techniques in the cervical region, as they have been shown to be comparably effective and less hazardous compared to paravertebral blocks

3 June 2020 in medRxiv
Verified
Preprint
Open access
PDF file
Kamil AdamczykKamil Adamczyk
Kamil Adamczyk
MHMichał Herman
Michał Herman
JFJanusz Frączek
Janusz Frączek
RPRobert Piec
Robert Piec
BPBarbara Szykula - Piec
Barbara Szykula - Piec
EFEdward Franek
Edward Franek
Objective: to quantitatively assess disturbances of sweet, sour and salty and bitter tastes in a group of young, asymptomatic or oligosymptomatic COVID-19 patients; establish a reliable, sensitive and specific test that can diagnose COVID-19 on the basis of taste disorders and publish the results according to STARD 2015 statement (Standards for Reporting Diagnostic Accuracy). Design: case-control study Setting: isolated rooms in the Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw (which had been transformed into an infectious hospital) and a dormitory in one of Warsaw universities. Participants: 52 SARS-CoV-2 positive (51 men, mean age 21.7 years) and 36 negative students (34 men, mean age 20.8 years). Main outcome measures: a gustatory function assessment (sweet, salty, sour and bitter taste), with flavour concentrations established previously in healthy subjects was conducted for all subjects. Each participant received one tasteless reference and nine flavour tablets with sucrose concentrations of 40, 80 and 106.4 mg/ml; NaCl at 13.5, 17 and 27 mg/ml; ascorbic acid at 6.25 and 12.5 mg/ml and grapefruit extract at 40 mg/ml. Results: the only taste that was impaired significantly more frequently in COVID-19 patients was the sweet taste at the lowest flavour concentration (40 mg/ml, p = 0.002). Different screening and diagnostic models were constructed using the examined variables. The highest accuracy screening test consisted of the positive result of a three-question questionnaire (self-reported loss of taste, self-reported loss of smell, or fever within the last month (positive if at least one present) and/or ageusia of sweet taste at a sucrose concentration of 40 mg/ml. The sensitivity of the model was 94% with a specificity of 55%. The highest accuracy diagnostic test consisted of ageusia of sweet taste at a sucrose concentration of 106.4 mg/ml or/and ageusia of salty taste at an NaCl concentration of 13.5 or 17 mg/ml. The specificity of the test was found to be 100%, and the sensitivity was 34%. Conclusion: as the most effective way of controlling the present pandemic involves testing the wider population for symptomatic, oligosymptomatic and asymptomatic carriers of SARSCoV-2 and isolating or hospitalising infected subjects, in the present study, an inexpensive, simple, fast and sensitive (94%) screening test that can be used for such a purpose is proposed. In addition, a specific (100%) diagnostic test that could be used to refer patients to quarantine in the case of limited availability of genetic or serological tests is proposed.

3 March 2025 in Cancers
Verified
Journal Article
Open access
PDF file
Kamil AdamczykKamil Adamczyk
Kamil Adamczyk
Konrad ZuzdaKonrad Zuzda
Konrad Zuzda
MJMilosz Jankowski
Milosz Jankowski
RŚRafał Świerczyński
Rafał Świerczyński
KCKamil Chudziński
Kamil Chudziński
KSKonstanty Szuldrzynski
Konstanty Szuldrzynski
Background/Objectives: Managing cancer-related pain presents complex challenges involving the interplay between analgesic efficacy, immune system responses, and patient outcomes. Methods: Following the Scale for the Assessment of Narrative Review Articles (SANRA) criteria, we conducted a comprehensive literature search in Medline, Scopus, and Web of Science databases. The review synthesized evidence regarding opioid pain management modalities, genetic variations affecting pain perception, and associated drug metabolism. Results: The literature reveals significant associations between opioid administration and immune function, with potential implications for cancer progression and survival. Genetic polymorphisms in key genes influence individual responses to pain opioid metabolism and, finally, pain management strategies. The immunosuppressive effects of opioids emerge as a critical consideration in cancer pain management, potentially influencing disease progression and treatment outcomes. Conclusions: Genetic variants influence analgesic efficacy, while the interaction between opioid-induced immunosuppression and genetic factors impacts both pain control and survival outcomes. This emphasizes the need for personalized treatment approaches considering individual genetic profiles and immune function.

18 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
KCKamil Chudziński
Kamil Chudziński
KSKonstanty Szuldrzynski
Konstanty Szuldrzynski
MJMilosz Jankowski
Milosz Jankowski
Kamil AdamczykKamil Adamczyk
Kamil Adamczyk
Colonoscopy is the gold standard for colorectal cancer screening and diagnosis of gastrointestinal disorders, yet the procedure can still provoke anxiety and pain in many patients. Advances in anesthesia and sedation techniques have significantly improved patient tolerance while maintaining procedural efficiency and safety. This review explores the physiological mechanisms of pain during colonoscopy, compares anesthetic and sedative agents—including newer drugs like remimazolam and dexmedetomidine—and evaluates emerging evidence from recent studies on sedation efficacy, safety, and patient outcomes. Special attention is given to high-risk patient populations, including those with obesity, obstructive sleep apnea, cardiovascular diseases, respiratory disorders and frailty syndrome. Propofol-based sedation remains the most commonly used agent for deep sedation. However, newer pharmacological agents with enhanced pharmacokinetic properties and improved safety profiles are increasingly influencing contemporary anesthesia practices. An individualized approach to sedation is essential. Incorporating current evidence into clinical decision-making optimizes both patient experience and procedural outcomes.

13 April 2024 in Medical Science Monitor
Verified
Journal Article
Open access
KCKamil Chudziński
Kamil Chudziński
KSKonstanty Szuldrzynski
Konstanty Szuldrzynski
MJMilosz Jankowski
Milosz Jankowski
Kamil AdamczykKamil Adamczyk
Kamil Adamczyk
ESElżbieta Sokół-Kobielska
Elżbieta Sokół-Kobielska
Comparison of Fentanyl, Ketamine, and Lidocaine Combined with Propofol Anesthesia in Patients with Crohn Disease Undergoing Colonoscopy - Article abstract #944116